Globus Medical (GMED) Tops Q1 EPS by 12c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Globus Medical (GMED) PT Raised to $73 at Stifel
May 5, 2021 9:36 AM EDTStifel analyst Mathew Blackman raised the price target on Globus Medical (NYSE: GMED) to $73.00 (from $60.00) while maintaining a Hold rating.
The analyst commented, "We expected GMED to post a strong 1Q, but the company's near-20% growth -- despite meaningful, early 1Q COVID... More
Globus Medical (GMED) PT Raised to $82 at Needham & Company
May 5, 2021 6:25 AM EDTNeedham & Company analyst Mike Matson raised the price target on Globus Medical (NYSE: GMED) to $82.00 (from $75.00) while maintaining a Buy rating.
The analyst commented, "GMED beat consensus revenue by 16% and EPS by 32% in 1Q21 driven by strong robotics implant pull-through, competitive rep hiring, new products,... More
